- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x NA: SODIUM ION(Non-functional Binders)
NA.2: 6 residues within 4Å:- Chain A: D.113, T.148, P.149, N.150, T.186
- Ligands: ATP.5
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:D.113, A:T.186
NA.10: 6 residues within 4Å:- Chain B: D.113, T.148, P.149, N.150, T.186
- Ligands: ATP.14
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.113, B:T.148
NA.25: 6 residues within 4Å:- Chain C: D.113, T.148, P.149, N.150, T.186
- Ligands: ATP.28
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:D.113
NA.33: 6 residues within 4Å:- Chain D: D.113, T.148, P.149, N.150, T.186
- Ligands: ATP.37
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:T.148, D:T.186
- 10 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.3: 5 residues within 4Å:- Chain A: C.5, L.31, G.32, H.246, K.247
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:G.32
- Water bridges: A:C.5
- Salt bridges: A:K.247
PO4.4: 1 residues within 4Å:- Chain A: G.159
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:G.159
PO4.11: 4 residues within 4Å:- Chain B: E.155, L.156, R.160, K.161
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.155
PO4.12: 5 residues within 4Å:- Chain B: C.5, L.31, G.32, F.33, H.246
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:L.31
- Salt bridges: B:H.246
PO4.13: 4 residues within 4Å:- Chain B: Q.63, Y.66, D.96, E.100
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:Q.63
PO4.26: 5 residues within 4Å:- Chain C: C.5, L.31, G.32, H.246, K.247
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:G.32
- Water bridges: C:C.5
- Salt bridges: C:K.247
PO4.27: 1 residues within 4Å:- Chain C: G.159
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:G.159
PO4.34: 4 residues within 4Å:- Chain D: E.155, L.156, R.160, K.161
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:E.155
PO4.35: 5 residues within 4Å:- Chain D: C.5, L.31, G.32, F.33, H.246
2 PLIP interactions:2 interactions with chain D- Hydrogen bonds: D:L.31
- Salt bridges: D:H.246
PO4.36: 4 residues within 4Å:- Chain D: Q.63, Y.66, D.96, E.100
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:Q.63
- 4 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
ATP.5: 24 residues within 4Å:- Chain A: D.113, V.115, D.118, Y.127, T.148, N.150, E.153, T.186, S.187, L.199, V.201, I.223, R.224, K.225, V.226, A.228, T.233, G.234, F.237, L.263, L.267
- Ligands: MG.1, NA.2, MPD.8
10 PLIP interactions:10 interactions with chain A- Hydrogen bonds: A:E.153, A:E.153, A:T.186, A:T.186, A:S.187, A:V.226, A:V.226, A:T.233, A:G.234
- Water bridges: A:D.235
ATP.14: 21 residues within 4Å:- Chain B: D.113, D.118, Y.127, T.148, N.150, E.153, T.186, S.187, L.199, V.201, R.224, K.225, V.226, A.228, T.233, G.234, L.263, L.267
- Ligands: MG.9, NA.10, MPD.22
13 PLIP interactions:13 interactions with chain B- Hydrogen bonds: B:Y.127, B:N.150, B:E.153, B:T.186, B:T.186, B:S.187, B:V.226, B:V.226, B:T.233
- Water bridges: B:T.148, B:F.230, B:T.233, B:D.235
ATP.28: 24 residues within 4Å:- Chain C: D.113, V.115, D.118, Y.127, T.148, N.150, E.153, T.186, S.187, L.199, V.201, I.223, R.224, K.225, V.226, A.228, T.233, G.234, F.237, L.263, L.267
- Ligands: MG.24, NA.25, MPD.31
14 PLIP interactions:14 interactions with chain C- Hydrogen bonds: C:Y.127, C:E.153, C:E.153, C:T.186, C:T.186, C:S.187, C:V.226, C:V.226, C:T.233, C:G.234
- Water bridges: C:D.118, C:D.118, C:T.148, C:D.235
ATP.37: 21 residues within 4Å:- Chain D: D.113, D.118, Y.127, T.148, N.150, E.153, T.186, S.187, L.199, V.201, R.224, K.225, V.226, A.228, T.233, G.234, L.263, L.267
- Ligands: MG.32, NA.33, MPD.45
11 PLIP interactions:11 interactions with chain D- Hydrogen bonds: D:N.150, D:E.153, D:T.186, D:T.186, D:S.187, D:V.226, D:V.226, D:T.233
- Water bridges: D:F.230, D:T.233, D:D.235
- 24 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
MPD.6: 7 residues within 4Å:- Chain A: Q.63, Y.66, R.70, M.93, D.96, I.97, E.100
Ligand excluded by PLIPMPD.7: 6 residues within 4Å:- Chain A: S.12, V.19, F.43, H.46, T.47, Y.84
Ligand excluded by PLIPMPD.8: 3 residues within 4Å:- Chain A: D.118
- Ligands: MG.1, ATP.5
Ligand excluded by PLIPMPD.15: 8 residues within 4Å:- Chain B: K.102, P.142, A.144, D.145, G.179, P.180, D.181
- Ligands: MPD.17
Ligand excluded by PLIPMPD.16: 9 residues within 4Å:- Chain B: S.12, V.19, G.20, H.46, T.47, Y.84, V.231, D.235
- Ligands: MPD.21
Ligand excluded by PLIPMPD.17: 5 residues within 4Å:- Chain B: D.181, R.206, R.207, R.208
- Ligands: MPD.15
Ligand excluded by PLIPMPD.18: 4 residues within 4Å:- Chain B: L.312
- Chain D: D.173, S.177, R.206
Ligand excluded by PLIPMPD.19: 4 residues within 4Å:- Chain B: H.248, P.249, N.250, N.251
Ligand excluded by PLIPMPD.20: 3 residues within 4Å:- Chain B: E.123, G.124, E.130
Ligand excluded by PLIPMPD.21: 6 residues within 4Å:- Chain B: F.43, W.52, V.56, Y.84, R.86
- Ligands: MPD.16
Ligand excluded by PLIPMPD.22: 4 residues within 4Å:- Chain B: D.118, L.199
- Ligands: MG.9, ATP.14
Ligand excluded by PLIPMPD.23: 1 residues within 4Å:- Chain B: P.191
Ligand excluded by PLIPMPD.29: 7 residues within 4Å:- Chain C: Q.63, Y.66, R.70, M.93, D.96, I.97, E.100
Ligand excluded by PLIPMPD.30: 6 residues within 4Å:- Chain C: S.12, V.19, F.43, H.46, T.47, Y.84
Ligand excluded by PLIPMPD.31: 3 residues within 4Å:- Chain C: D.118
- Ligands: MG.24, ATP.28
Ligand excluded by PLIPMPD.38: 8 residues within 4Å:- Chain D: K.102, P.142, A.144, D.145, G.179, P.180, D.181
- Ligands: MPD.40
Ligand excluded by PLIPMPD.39: 9 residues within 4Å:- Chain D: S.12, V.19, G.20, H.46, T.47, Y.84, V.231, D.235
- Ligands: MPD.44
Ligand excluded by PLIPMPD.40: 5 residues within 4Å:- Chain D: D.181, R.206, R.207, R.208
- Ligands: MPD.38
Ligand excluded by PLIPMPD.41: 4 residues within 4Å:- Chain B: D.173, S.177, R.206
- Chain D: L.312
Ligand excluded by PLIPMPD.42: 4 residues within 4Å:- Chain D: H.248, P.249, N.250, N.251
Ligand excluded by PLIPMPD.43: 3 residues within 4Å:- Chain D: E.123, G.124, E.130
Ligand excluded by PLIPMPD.44: 6 residues within 4Å:- Chain D: F.43, W.52, V.56, Y.84, R.86
- Ligands: MPD.39
Ligand excluded by PLIPMPD.45: 4 residues within 4Å:- Chain D: D.118, L.199
- Ligands: MG.32, ATP.37
Ligand excluded by PLIPMPD.46: 1 residues within 4Å:- Chain D: P.191
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Musayev, F.N. et al., Crystal Structure of human pyridoxal kinase: structural basis of M(+) and M(2+) activation. Protein Sci. (2007)
- Release Date
- 2008-03-11
- Peptides
- Pyridoxal kinase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.20 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x MG: MAGNESIUM ION(Non-covalent)
- 4 x NA: SODIUM ION(Non-functional Binders)
- 10 x PO4: PHOSPHATE ION(Non-functional Binders)
- 4 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 24 x MPD: (4S)-2-METHYL-2,4-PENTANEDIOL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Musayev, F.N. et al., Crystal Structure of human pyridoxal kinase: structural basis of M(+) and M(2+) activation. Protein Sci. (2007)
- Release Date
- 2008-03-11
- Peptides
- Pyridoxal kinase: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
AD
B